In contrast, the total MoCA score, and memory and orientation subscores did not differ from expected ranges. On the MoCA test, executive functions, particularly phonemic fluency, and attention, were impaired. Between December 2020 and June 2021, 46 patients were referred for neurological consultation (65% female), mean age 49.5 (19-72 years). The neurologic work-up included detailed medical history, symptom inventory, neurological examination, the Montreal Cogni-tive Assessment (MoCA), laboratory tests and brain CT or MRI. Patients evaluated at a post COVID clinic in Northern Israel who endorsed cognitive symptoms were referred for neurologic consultation. The present study aims to characterize cognitive performance in patients experiencing cognitive symptoms post-COVID infection. The long-term sequelae of COVID-19 and neurologic syndromes post COVID remain poorly understood. The coronavirus (COVID-19) pandemic is still evolving, causing hundreds of millions of infections around the world. As a screening instrument for MCI, its higher sensitivity makes it preferable o the MMSE, which is used extensively in the clinical setting. The Hebrew version of the MoCA test is effective for identifying MCI in older patients. The Hebrew version of MoCA distinguished between cognitively asymptomatic older individuals and those with MCI, with a sensitivity of 94.6% and a specificity of 76.3%, using a cutoff of 26/30 points. Cognitive evaluation included the Mini-Mental State Examination (MMSE), Mindstreams computerized cognitive assessment, and the MoCA test. The study population consisted of 2 groups of older individuals, 74 patients diagnosed with MCI and 80 patients who were cognitively asymptomatic. However, the sensitivity and specificity of the Hebrew version of this instrument are yet to be determined. The English version of the Montreal Cognitive Assessment (MoCA) test has been shown to be reliable in screening for mild cognitive impairment (MCI).
0 kommentar(er)
